If Vivek Kopparthi had his way, each community in developing countries around the world would have one of his devices. The co-founder and CEO of NeoLight, an Arizona-based healthcare startup, believes his company’s backpack-sized device can significantly improve the survival rates of infants, particularly those who are afflicted with jaundice.
The concept behind this startup is strikingly straightforward. The treatment involves phototherapy, which basically uses targeted amounts of light to break down excess bilirubin molecules into water-soluble isomers that are then safely excreted by the body.
